Since March 2011, NPC has been posting on its website (http://pharma.us.novartis.com/index.jsp) a listing of all US-based physicians who have received payments, fees or honoraria, either directly or indirectly, in connection with promotional speaker programs and/or promotional speaker training. Please click to view the report which covers the timeframe of October 1, 2010 through September 30, 2011 for the following interactions:
In addition to the direct/indirect payments, fees or honoraria in connection with promotional speaker programs and/or promotional speaker training, since October, 2011, NPC has also been tracking all payments or transfers of value to physicians and related entities*, including fees for services, meals, travel and other expense reimbursements, and educational items. Please click to view the quarterly report which covers the timeframe of October 1, 2011 through September 30, 2012 for the following interactions:
Promotional Speaker Program Fees & Honoraria
Promotional Speaker Training Fees & Honoraria
Speaker training event
"Lunch and Learns"
Advisory boards (marketing and scientific)
Consulting arrangements (commercial and medical)
Market research activities
Effective March 1, 2012, NPC began including information about these payments and transfers of value to the information already posted on NPC' website for promotional speaker programs and promotional speaker training. Effective September 30, 2014, the posting will be updated twice per year in order to better align these payment postings with the Open Payments (Sunshine) reporting requirements. Please click below to view report.
Effective March 1, 2013, NPC began reporting information as it relates to clinical investigations, product research, and development agreements. The list below outlines the payments and transfers of value to physicians and related entities included in subsequent reports. Please click to view the report which covers the timeframe of January 1, 2011 through December 31, 2012 for the following interactions:
Novartis acquired certain oncology products from GlaxoSmithKline (GSK) in March 2015. After the products were acquired by Novartis, GSK continued to provide certain payments and transfers of value associated with those products to Healthcare Professionals. As part of Novartis Pharmaceuticals Corporation's Year 5 CIA Healthcare Professional Payment Disclosure Phase III Reporting obligation, information about payments and transfers of value provided by GSK with respect to the oncology products now owned by Novartis, is available here:
Please click here for a listing of Frequently Asked Questions that provide more information about NPC's disclosure of physician payments. If you would like to speak with a specialist directly, please call 1-866-356-8735 or submit your question here.
NPC believes that disclosing its payments related to interactions with physicians and related entities helps foster trust and supports our commitment to maintaining the highest ethical standards in the work we do.
*A related entity is an entity by or in which any physician receiving payments is employed, has tenure or has an ownership interest.